| 13-May-2023 | S | The Board considered the proposal for sub-division of 1 equity share of the Company having facé value of Rs.10/- each into 10 ({Ten) equity shares having face value of Rs.1/- each, subject to regulatory/statutory approvals as may be required and the approval of the shareholders of the Company.
7. The Board considered the proposal for sub-division of 1 equity share of the Company having face value of Rs.10/- each into 10 (Ten) equity shares having face value of Rs.1/- each, subject to regulatory/statutory approvals as may be required and the approval of the shareholders of the Company. Further, the Board recommended consequential amendments in the Capital Clause of the Memorandum of Association of the Company and Articles of Association of the Company, subject to approval of the Shareholders of the Company. The record date for the sub-division of equity shares shall be decided by the Board and will be intimated to the exchanges. The detailed disclosure as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015 read with SEBI Circular No. CIR/CFD/CMD/ 4/2015 dated September 9, 2015 is enclosed herewith as Annexure ll.
Please find our intimation under Regulation 42 of the SEBI (LODR) Regulations, 2015
(As Per BSE Announcement Dated on 20/09/2023)
Trading Members of the Exchange are hereby informed that THEMIS MEDICARE LTD., has fixed Record Date for the purpose of Sub-Division of the Equity Shares of the Company :-
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
THEMIS MEDICARE LTD.
(530199)
RECORD DATE
10.10.2023
PURPOSE
Subdivision of existing Equity Shares from One Equity Share of Rs.10/- each into Ten Equity Shares of Re. 1/- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
10/10/2023 DR-630/2023-2024
Note: -
i. ISIN No. INE083B01016 of Rs. 10/- paid up will not be valid for transactions done on the Exchange on or after 10/10/2023.
ii. The new ISIN Number for Re. 1/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 26..09.2023)
Sub: Change in ISIN - Themis Medicare Limited (THEMISMED)
Members of the Exchange are hereby informed that the ISIN Code for the equity shares of the following company shall be changed w.e.f. October 10, 2023.
Symbol
THEMISMED
Company Name
Themis Medicare Limited
New ISIN
INE083B01024
Remarks
Sub-Division from Rs. 10/- to Re. 1/-
The new ISIN shall be effective for all trades done on and from the Ex-date date i.e., October 10, 2023.
For and on behalf of
National Stock Exchange of India Limited
(As Per NSE Circular Dated on 04.10.2023) | 10-Oct-2023 | |
| 13-May-2023 | D | 2. Recommended dividend for Financial Year ended 31.03.2023 of Rs. 5/- i.e. @ 50% per equity share having face value of Rs.10/- aggregating to Rs. 4,60,13,850/-. The payment is subject to the approval of shareholders at the ensuing AGM.
The Register of Members and Share Transfer Books of the Company will remain closed for payment of dividend and AGM from Saturday 02' September , 2023 fo saturday 09t September , 2023 (both days inclusive).
| 01-Sep-2023 | |
| 23-May-2022 | D | Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2022, inter alia, has recommended dividend for Financial Year ended March 31, 2022 of Rs. 5.00/- (Rupees Five only) i.e. @ 50% per equity share having face value of Rs. 10/-, aggregating to Rs. 460.02 lacs. The payment is subject to the approval of shareholders at the ensuing AGM.
| 08-Sep-2022 | |
| 27-May-2021 | D | Recommended dividend for Financial Year ended 31.03.2021 of Rs.4.30/- (Re only.) per equity share having face value of Rs.10/- each, aggregating to Rs. 395.10 lacs. The payment is subject to the approval of shareholders at the ensuing AGM. | 08-Sep-2021 | |
| 08-Jun-2020 | D | Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 08, 2020, inter alia, has recommended dividend for Financial Year ended March 31, 2020 of Rs. 1.75/- (Re One Paise Seventy five only) per equity share having face value of Rs. 10/- each, aggregating to Rs. 160.79 lacs. The payment is subject to the approval of shareholders at the ensuing AGM. | 17-Sep-2020 | |
| 03-May-2011 | D | Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 03, 2011, inter alia, has recommended Dividend of Rs. 3 per share (i.e. @ 30%) on Equity Shares as well as transfer General Reserve of Rs. 3.00 Crores. | 20-Jul-2011 | |
| 27-Apr-2010 | D | Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2010, inter alia, has recommended Dividend of Rs. 3 per share (i.e. @ 30%) on Equity Shares as well as transfer to General Reserve of Rs. 3 crores. | 16-Jun-2010 | |
| 18-Jun-2008 | D | Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 18, 2008, inter alia, has recommended dividend @ 25 % subject to approval by members at the forthcoming Annual General Meeting | 01-Aug-2008 | |
| 29-Jun-2007 | D | Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 29, 2007, inter alia, has recommended 20% dividend for the year 2006-07. | 14-Sep-2007 | |
| 20-Jun-2005 | D | 25% Dividend | 03-Aug-2005 | |
| 10-Feb-2024 | BC | Approved Notice of the Postal Ballot for seeking shareholders' approval for material related party transaction(s)
Please find attached our intimation along with the Notice of Postal Ballot of the | 07-Apr-2024 | |
| 28-Feb-2024 | BC | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursd | 29-Feb-2024 | |
| 29-Jan-2024 | BC | THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve Un-audited Standalone and Consolidated Fin | 10-Feb-2024 | |
| 05-Jan-2024 | BC | Source: BSE Announcement PDF
| 04-Jan-2024 | |
| 05-Jan-2024 | BC | Source: BSE Announcement PDF
| 04-Jan-2024 | |
Announcement Date13-May-2023
Ex Dividend Date01-Sep-2023
Dividend(%)50
Announcement Date23-May-2022
Ex Dividend Date08-Sep-2022
Dividend(%)50
Announcement Date27-May-2021
Ex Dividend Date08-Sep-2021
Dividend(%)43
Announcement Date08-Jun-2020
Ex Dividend Date17-Sep-2020
Dividend(%)18
Announcement Date03-May-2011
Ex Dividend Date20-Jul-2011
Dividend(%)30
Announcement Date27-Apr-2010
Ex Dividend Date16-Jun-2010
Dividend(%)30
Announcement Date18-Jun-2008
Ex Dividend Date01-Aug-2008
Dividend(%)25
Announcement Date29-Jun-2007
Ex Dividend Date14-Sep-2007
Dividend(%)20
Announcement Date20-Jun-2005
Ex Dividend Date03-Aug-2005
Dividend(%)25
No Bonus has been declared by THEMISMED
Record Date10-Oct-2023
Split Date10-Oct-2023
Face Value (Before/After)10/1
RightsNo Rights has been declared by THEMISMED
Book Closure
| 07-Apr-2024 | 01 Jan'1900 | Approved Notice of the Postal Ballot for seeking shareholders' approval for material related party transaction(s)
Please find attached our intimation along with the Notice of Postal Ballot of the |
| 29-Feb-2024 | - | Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Thursd |
| 10-Feb-2024 | - | THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 inter alia to consider and approve Un-audited Standalone and Consolidated Fin |
| 04-Jan-2024 | 01 Jan'1900 | Source: BSE Announcement PDF
|
| 04-Jan-2024 | 01 Jan'1900 | Source: BSE Announcement PDF
|